Q&A with Jaime Davidson from UT Southwestern: New Tool Looks to Bridge the Gap Between Latino Patients with Diabetes and Doctors

Video

There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.

There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.

Jaime Davidson, MD, from the University of Texas Southwestern Medical Center at Dallas, discussed a tool developed by Janssen Pharmaceuticals designed to bridge that gap during the American Diabetes Association's 75th Annual Scientific Sessions in Boston.

Known as the Diabetes Medication Options decision aid, Davidson said there are components patients can use at home and with the doctors to help them with their treatment even when English is not their primary language. Among the topics covered by the tool, in both English and Spanish, are the efficacy of treatment options, their safety profiles, and how they're administered as well as costs associated with the therapies. More information about the tool can be found here.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.